Results

1–10 of 62 results for socioeconomic

Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs
Ravi Parikh, MD MPH
Annual Meeting Talks
2023
Economic Benefit of Higher Durability Anti-VEGF Agents in the Treatment of Neovascular Macular Degeneration
Sabin Dang, MD
Annual Meeting Talks
2023
Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023
Inflation-Adjusted Trends in Medicare Reimbursement for Retina Practice Expenses
Philip I Niles, MD, MBA
Annual Meeting Talks
2023
Demographic and Socioeconomic Predictors of Visual Outcomes in Pediatric Uveitis: An IRIS Registry Study
Akshay S Thomas, MD, MS, FASRS
Annual Meeting Talks
2023
Expert Panel: Socioeconomics
Linda A. Lam, MD, MBA, FASRS
Ella H Leung, MD
Mohsin H. Ali, MD
Hasenin Al-khersan, MD
Miguel A. Busquets, MD, FACS
Annual Meeting Talks
2024
Expert Panel: Sustainability
Geoffrey G. Emerson, MD, PhD, FASRS
Jacob D. Grodsky, MD
David R Anderson, MD, PharmD
Scott M McClintic, MD
Annual Meeting Talks
2024
A Discussion on Physician Contract Negotiations
Alexis Warren, MD
Talia R Kaden, MD
Jonathan Jonisch, MD
Webinars and Journal Clubs
2025
Disparities in Utilization, Payments, and Follow-up of Teleophthalmology for Remote Diabetic Retinopathy Screening
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2024
Individual and Neighborhood-Level Socioeconomic Characteristics Associated With Presenting Visual Acuity and Foveal Status in Rhegmatogenous Retinal Detachment
Sally S Ong, MD
Annual Meeting Talks
2024